Funder
National Research Foundation of Korea
Publisher
Springer Science and Business Media LLC
Subject
Computer Science Applications,Biomedical Engineering,Medicine (miscellaneous),Bioengineering,Biotechnology
Reference93 articles.
1. Boras, B. et al. Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19. Nat. Commun. 12, 6055 (2021).
2. Ma, F. et al. Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection. Sci. Adv. 6, eabb4429 (2020).
3. FDA approves first treatment for COVID-19. US Food and Drug Administration https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19 (2020).
4. Wei, F., Chen, W. & Lin, X. A clinical rule for the difficulty prediction on scalp intravenous access in infants (SIAI) from emergency room. Sci. Rep. 10, 6624 (2020).
5. Finfer, S., Myburgh, J. & Bellomo, R. Intravenous fluid therapy in critically ill adults. Nat. Rev. Nephrol. 14, 541–557 (2018).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献